Intezyne Technologies Inc.
USPTO PatentsView assignee record - 13 granted patents across 9 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Intezyne ranks #21,287 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 9 technology areas.
- #21,287
- of 49,997 US assignees by volume
- 44th percentile
- by Innovation Score (33.3/100)
- 11.5
- avg claims per patent
- -70%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R21287 · US Corporation #21,287 · 13 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 13 grants
- MID-PACK #21,287/49,997
- PHOTO-FINISH Intellia Therapeutics
- CPC-NARROW A61K · 9 areas
- INNOV-THIN 33.3/100
- CLAIMS-PAR 11.5 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -70% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Intellia Therapeutics, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Intezyne’s 33.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Intezyne
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Intezyne · this assignee 33
Intezyne · this assignee
33 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Intezyne's Innovation Score is 33.3/100 (44th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Intezyne?
Each dot is one of Intezyne’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Intezyne’s own 11.5 claims/patent is at or below the 17.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Intezyne's grants concentrate
Intezyne Technologies Inc. is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2018 (4 grants) versus a trough of 1 in 2019. By volume, Intezyne sits between Intellia Therapeutics, Inc. and J&M Shuler Medical, Inc..
Intezyne's three-year grant acceleration
Intezyne Technologies Inc. shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Intezyne's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Intellia Therapeu…
Intellia Therapeutics, Inc.
13 patents
- Intellitact
Intellitact LLC
13 patents
- Intermountain Int…
Intermountain Intellectual Asset Management, LLC
13 patents
- International IP…
International IP Holdings LLC
13 patents
- Invoy
Invoy Technologies, LLC
13 patents
- Irvine Sensors
Irvine Sensors Corp.
13 patents
- Isola USA
Isola USA Corp.
13 patents
- J&M Shuler Medical
J&M Shuler Medical, Inc.
13 patents
- Intezyne ◀
Intezyne Technologies Inc.
13 patents
What this shows Intezyne holds 13 patents at rank #21,295, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Intezyne
By rank, the assignees closest to #21,295 in granted patent volume.
- Intellia Therapeutics, Inc. #21,291 · 13 patents
- Intellitact LLC #21,292 · 13 patents
- Intermountain Intellectual Asset Management, LLC #21,293 · 13 patents
- International IP Holdings LLC #21,294 · 13 patents
- Invoy Technologies, LLC #21,296 · 13 patents
- Irvine Sensors Corp. #21,297 · 13 patents
- Isola USA Corp. #21,298 · 13 patents
- J&M Shuler Medical, Inc. #21,299 · 13 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Intezyne's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Intezyne's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
33 44th percentile higher than 44% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 23.1% |
| 2016 | 2 | 15.4% |
| 2018 | 4 | 30.8% |
| 2019 | 1 | 7.7% |
| 2020 | 1 | 7.7% |
| 2022 | 1 | 7.7% |
| 2024 | 1 | 7.7% |
Which technologies does Intezyne Technologies Inc. patent most?
Top 9 of 9 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Intezyne Technologies Inc.'s patent record in context - here's where to go next.
- Intezyne Technologies Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #21,287 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Intezyne Technologies Inc. against Intellia Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 33.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.